A

ANIK

Anika Therapeutics Inc

14.69

0.18+1.24%
After Hours: 14.69  0.00  0.00%16:00 04/29 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

119.91M

120.79M

113.83M

147.79M

130.46M

Net Income

-56.38M

-82.67M

-14.86M

4.13M

-23.98M

ROE

-0.3079

-0.3321

-0.0519

0.0148

-0.0855

ROA

-0.2382

-0.2668

-0.0427

0.0116

-0.0689

EPS

-3.8302

-5.6405

-1.0205

0.2825

-1.6863

BVPS

10.6818

14.4792

19.5257

19.8799

19.0104

Asset Turnover

0.5066

0.3898

0.3268

0.4145

0.3747

Debt-to-Asset

0.2405

0.2157

0.1821

0.1739

0.2549

Current Ratio

4.8765

5.258

6.0739

5.6563

4.8114

Quick Ratio

3.8549

3.7645

4.6494

4.4477

3.558